Starbucks News and Analysis: SBUX earnings push stock down below critical support
Premium|Take advantage of 75% OFF on your first month.
Grab this special offer, it's a 1 year for FREE deal! And access ALL our articles and analysis.
You have reached your limit of 5 free articles for this month.
BLACK FRIDAY SALE! 75% OFF!
Grab this special offer, it's a 1 year for FREE deal! And access ALL our articles and analysis.
CLAIM OFFERStarbucks is down 5.8% in the Friday premarket after reporting earnings Thursday evening that missed Wall Street estimates for revenue. The office worker energizer reported $8.1 billion in fiscal fourth quarter revenue against estimates of $8.22 billion. Though adjusted earnings per share (EPS) of $1 came in a penny over consensus, the market looked askew at same store sales growth both in the US and internationally coming in below expectations. Sales in China fell 7%. Likewise, 2022 EPS guidance near $3.40 was below analyst estimates for $3.73.
SBUX stock breaks critical support
It may not have happened in the public trading hours yet, but SBUX stock's premarket fall on Friday in the face of disappointing earnings brought it below a critical support level that it has bounced off of a total of five times since early. This tough support level surronds $109.50. On May 13 and 19, June 18, and October 6 and 13 SBUX price bounced off this region before reversing higher. At $106.62 in the premarket, SBUX has broken through what was until now solid support.
At the current premarket price, SBUX is just under a second support line at $107.50. This level, which served as resistance on January 4 and February 5, may serve as a bottom once the regular market opens. If not, Starbucks stock could trend as low as $100.
We at FXStreet think this is unlikely though. Starbucks has raised its dividend for 11 years in a row and is thus a staple of large institutional buyers intent on dollar cost averaging into dependable dividend growers. SBUX is just too attractive at these prices to stay here long.
Some investors might get cold feet after the analyst downgrades. Stifel dowgraded SBUX to Hold. Cowen & Co. cut its price target to $125, while Oppenheimer cut their target to $130.
SBUX 1-day chart
Starbucks is down 5.8% in the Friday premarket after reporting earnings Thursday evening that missed Wall Street estimates for revenue. The office worker energizer reported $8.1 billion in fiscal fourth quarter revenue against estimates of $8.22 billion. Though adjusted earnings per share (EPS) of $1 came in a penny over consensus, the market looked askew at same store sales growth both in the US and internationally coming in below expectations. Sales in China fell 7%. Likewise, 2022 EPS guidance near $3.40 was below analyst estimates for $3.73.
SBUX stock breaks critical support
It may not have happened in the public trading hours yet, but SBUX stock's premarket fall on Friday in the face of disappointing earnings brought it below a critical support level that it has bounced off of a total of five times since early. This tough support level surronds $109.50. On May 13 and 19, June 18, and October 6 and 13 SBUX price bounced off this region before reversing higher. At $106.62 in the premarket, SBUX has broken through what was until now solid support.
At the current premarket price, SBUX is just under a second support line at $107.50. This level, which served as resistance on January 4 and February 5, may serve as a bottom once the regular market opens. If not, Starbucks stock could trend as low as $100.
We at FXStreet think this is unlikely though. Starbucks has raised its dividend for 11 years in a row and is thus a staple of large institutional buyers intent on dollar cost averaging into dependable dividend growers. SBUX is just too attractive at these prices to stay here long.
Some investors might get cold feet after the analyst downgrades. Stifel dowgraded SBUX to Hold. Cowen & Co. cut its price target to $125, while Oppenheimer cut their target to $130.
SBUX 1-day chart
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.